53 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
OWNERS AND MANAGEMENT
FUTURE SHAREHOLDER PROPOSALS
OTHER MATTERS
WHERE YOU CAN FIND MORE INFORMATION
MISCELLANEOUS
ii
SUMMARY
This summary … , 2023, through the exercise of stock options.
FUTURE SHAREHOLDER PROPOSALS
If the Merger is completed, we will have no public ImmunoGen Shareholders
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
AND MANAGEMENT
FUTURE SHAREHOLDER PROPOSALS
OTHER MATTERS
WHERE YOU CAN FIND MORE INFORMATION
MISCELLANEOUS
ii
SUMMARY
This summary highlights … executive officers in the aggregate within 60 days of December 15, 2023 through the exercise of stock options.
FUTURE SHAREHOLDER PROPOSALS
424B5
IMGN
Immunogen, Inc.
5 May 23
Prospectus supplement for primary offering
4:49pm
plan, or “poison pill,” which could have the effect of discouraging or delaying a takeover of the company.
Advance notice provisions for shareholder … proposals and shareholder nominations of directors. Our amended and restated by-laws provide that, for nominations to the board of directors
424B5
IMGN
Immunogen, Inc.
3 May 23
Prospectus supplement for primary offering
4:05pm
,” which could have the effect of discouraging or delaying a takeover of the company.
Advance notice provisions for shareholder proposals and shareholder
424B5
4zd4ya3pij 7slqt11
3 Dec 21
Prospectus supplement for primary offering
4:06pm
424B5
z5568h2
30 Nov 21
Prospectus supplement for primary offering
5:12pm
424B5
gqh68b5ugyukkkv1
12 Aug 21
Prospectus supplement for primary offering
10:11am
424B5
7udigl9alyj3wf hk
18 Dec 20
Prospectus supplement for primary offering
5:16pm
S-3ASR
z9bp5
18 Dec 20
Automatic shelf registration
4:45pm
424B5
eo7 bzsue
25 Sep 20
Prospectus supplement for primary offering
4:23pm
424B5
u4nv5z
23 Jan 20
Prospectus supplement for primary offering
4:05pm
424B5
5yrnh
22 Jan 20
Prospectus supplement for primary offering
4:07pm